RxDoctor Payments Data

Kelly Bridges, MD

Neurological Surgery · Boise, IDNPI 1871883660

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson at 50.4% of the total. Reporting peaked in 2019 at $688 and has fallen 82.3% since, to $122 in 2025. That places this record below the midpoint for neurological surgery clinicians in ID, where the typical reported total is $1,838.

$2,026in general payments, 2019–2025

Across 23 payments — averaging $88.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Intrinsic Therapeutics$252
  • Abbott$217
  • Vertex$122
  • Surgalign Spine Technologies, Inc.$117
  • Bioventus LLC$116
  • plus $183 from 2 others

What the payments were for

  • Food & beverage$2,026100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,026 in reported general payments places this provider in the 50th percentile of 43 neurological surgery providers in Idaho.

See all neurological surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$128,933
Medicare patients
136
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl48$444
Cyclobenzaprine Hcl47$420
Ondansetron OdtOndansetron22$188
Methylprednisolone21$126
Tramadol Hcl27$119
Methocarbamol16$110
Gabapentin12$87

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →